Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Milou C. Schimmelpennink"'
Publikováno v:
EJNMMI Research, Vol 9, Iss 1, Pp 1-7 (2019)
Abstract Background 18F-FDG PET/CT has proven to be a reliable tool for therapy monitoring in sarcoidosis. Previous PET studies investigated the SUVmax as a marker for disease activity. Total lung glycolysis (TLuG) is a new tool, quantifying the glyc
Externí odkaz:
https://doaj.org/article/c46ad77df8be439c8c11a5337693fb5c
Autor:
Els Beijer, Claudia Roodenburg-Benschop, Milou C. Schimmelpennink, Jan C. Grutters, Bob Meek, Marcel Veltkamp
Publikováno v:
Cells, Vol 10, Iss 3, p 585 (2021)
Elevated Serum Amyloid A (SAA) levels have been found in several inflammatory diseases, including sarcoidosis. SAA is suggested to be involved in sarcoidosis pathogenesis by involvement in granuloma formation and maintenance. We hypothesized that SAA
Externí odkaz:
https://doaj.org/article/516b4d4d98464ee98e1830c1281b0982
Publikováno v:
EJNMMI Research, Vol 9, Iss 1, Pp 1-7 (2019)
EJNMMI Research
EJNMMI Research
Background 18F-FDG PET/CT has proven to be a reliable tool for therapy monitoring in sarcoidosis. Previous PET studies investigated the SUVmax as a marker for disease activity. Total lung glycolysis (TLuG) is a new tool, quantifying the glycolysis of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9700bde46a225a26712ad7a7ecef65e6
http://link.springer.com/article/10.1186/s13550-019-0505-x
http://link.springer.com/article/10.1186/s13550-019-0505-x
Autor:
Jan C. Grutters, Claudia Roodenburg-Benschop, Bob Meek, Marcel Veltkamp, Milou C. Schimmelpennink, Els Beijer
Publikováno v:
Cells
Volume 10
Issue 3
Cells, Vol 10, Iss 585, p 585 (2021)
Volume 10
Issue 3
Cells, Vol 10, Iss 585, p 585 (2021)
Elevated Serum Amyloid A (SAA) levels have been found in several inflammatory diseases, including sarcoidosis. SAA is suggested to be involved in sarcoidosis pathogenesis by involvement in granuloma formation and maintenance. We hypothesized that SAA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45affebbdedb958e998baccf67f30ea7
Autor:
Frouke T. van Beek, Marcel Veltkamp, Milou C. Schimmelpennink, Adriane D.M. Vorselaars, Ruth G.M. Keijsers, Heleen A. Crommelin, Vera H.M. Deneer
Publikováno v:
Respiratory Medicine. 138:S7-S13
Background Infliximab, a monoclonal antibody against tumor necrosis factor alpha (TNF-α) is effective third-line therapy in severe sarcoidosis. The originator product of Infliximab, Remicade®, is expensive, limiting universal access. Recently, a le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b7dd966ccd16e45f2e107695c538102
https://doi.org/10.1016/j.rmed.2018.02.009
https://doi.org/10.1016/j.rmed.2018.02.009
Publikováno v:
Bijblijven. 34:117-128
Sommige patienten met therapieresistente chronische sarcoidose komen in aanmerking voor een derdelijns behandeling met TNF-alfaremmers. Middelen zoals infliximab en adalimumab zijn beide effectief gebleken in de behandeling van patienten met chronisc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f319ca758edd4a08abff59674d4fd6dc
https://doi.org/10.1007/s12414-018-0298-2
https://doi.org/10.1007/s12414-018-0298-2
Autor:
Alejandro Aragaki, Zahir Amoura, Robert Phillip Baughman, Sadia Benzaquen, Jean-François Bernaudin, Valérie Besnard, Surinder S. Birring, Diane Bouvry, Pierre-Yves Brillet, Pilar Brito-Zerón, Caroline E. Broos, Thibaud Chazal, Ozioma S. Chioma, Fleur Cohen Aubart, Elliott D. Crouser, Daniel A. Culver, Jolanda De Vries, Morgane Didier, Wonder P. Drake, Marjolein Drent, Marjon Elfferich, Joseph C. English, Alexander Gelbard, Kareem Genena, Milanese Gianluca, Jan C. Grutters, Celine Hendriks, Sotonye Imadojemu, W. Ennis James, Florence Jeny, Marc A. Judson, Marianne Kambouchner, R.G.M. Keijsers, Belchin Kostov, Van Le, Raphaël Lhote, Huiping Li, Elyse E. Lower, Silva Mario, Edward J. Miller, Kool Mirjam, Philippe Moguelet, Sverzellati Nicola, Megan Noe, Hilario Nunes, Amit S. Patel, Manuel Ramos-Casals, Misha Rosenbach, Nathalie Saidenberg-Kermanac’h, Milou C. Schimmelpennink, Zartashia Shahab, Sumit Sharma, Paolo Spagnolo, Timothy Tully, Yurdagül Uzunhan, V. Kouranos, Dominique Valeyre, Merilyn Varghese, Adriane D.M. Vorselaars, Karolyn A. Wanat, Athol Wells, Wim Wuyts, Jonas Yserbyt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44c4c2d9561d7d8ebe208a21f9313471
https://doi.org/10.1016/b978-0-323-54429-0.01002-8
https://doi.org/10.1016/b978-0-323-54429-0.01002-8
Publikováno v:
Sarcoidosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3cd10ba5e47ee53661e2ada436ece7e1
https://doi.org/10.1016/b978-0-323-54429-0.00019-7
https://doi.org/10.1016/b978-0-323-54429-0.00019-7
Autor:
Milou C, Schimmelpennink, Adriane D M, Vorselaars, Frouke T, van Beek, Heleen A, Crommelin, Vera H M, Deneer, Ruth G M, Keijsers, Marcel, Veltkamp
Publikováno v:
Respiratory medicine.
Infliximab, a monoclonal antibody against tumor necrosis factor alpha (TNF-α) is effective third-line therapy in severe sarcoidosis. The originator product of Infliximab, RemicadeIn this retrospective cohort study, 29 patients treated with the infli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::70f04e72e6ea9994119bd1ec5e21c0d9
https://pubmed.ncbi.nlm.nih.gov/29496351
https://pubmed.ncbi.nlm.nih.gov/29496351
Autor:
Adriane D.M. Vorselaars, Ruth G.M. Keijsers, Marcel Veltkamp, Heleen C. Crommelin, Milou C. Schimmelpennink, Frouke T. van Beek
Publikováno v:
Diffuse Parenchymal Lung Disease.
Background: Infliximab, a monoclonal antibody against tumor necrosis factor alpha (TNF-α) is effective third-line therapy for severe sarcoidosis patients. The originator product of Infliximab, Remicade®, is expensive, which limits universal access.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b53fbc57c9514c1cdfe7854b5ded7fb
https://doi.org/10.1183/1393003.congress-2017.pa3259
https://doi.org/10.1183/1393003.congress-2017.pa3259